Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

29 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Pathogenic mechanisms of polymorphic light eruption.
Gruber-Wackernagel A, Byrne SN, Wolf P. Gruber-Wackernagel A, et al. Front Biosci (Elite Ed). 2009 Jun 1;1:341-54. Front Biosci (Elite Ed). 2009. PMID: 19482651 Review.
CD11b+ cells markedly express the itch cytokine interleukin-31 in polymorphic light eruption.
Patra V, Strobl J, Gruber-Wackernagel A, Vieyra-Garcia P, Stary G, Wolf P. Patra V, et al. Among authors: gruber wackernagel a. Br J Dermatol. 2019 Nov;181(5):1079-1081. doi: 10.1111/bjd.18092. Epub 2019 Jul 21. Br J Dermatol. 2019. PMID: 31049931 Free PMC article. No abstract available.
Influence of the season on vitamin D levels and regulatory T cells in patients with polymorphic light eruption.
Schweintzger NA, Gruber-Wackernagel A, Shirsath N, Quehenberger F, Obermayer-Pietsch B, Wolf P. Schweintzger NA, et al. Among authors: gruber wackernagel a. Photochem Photobiol Sci. 2016 Mar;15(3):440-6. doi: 10.1039/c5pp00398a. Epub 2016 Feb 25. Photochem Photobiol Sci. 2016. PMID: 26911519 Free PMC article. Clinical Trial.
Levels and function of regulatory T cells in patients with polymorphic light eruption: relation to photohardening.
Schweintzger N, Gruber-Wackernagel A, Reginato E, Bambach I, Quehenberger F, Byrne SN, Wolf P. Schweintzger N, et al. Br J Dermatol. 2015 Aug;173(2):519-26. doi: 10.1111/bjd.13930. Epub 2015 Jul 30. Br J Dermatol. 2015. PMID: 26032202 Free PMC article. Clinical Trial.
Short- to intermediate-term follow-up in patients treated with the combination of 311-nm ultraviolet B phototherapy and biological agents.
Inzinger M, Legat FJ, Hofer A, Weger W, Gruber-Wackernagel A, Salmhofer W, Wolf P. Inzinger M, et al. Br J Dermatol. 2014 Oct;171(4):915-7. doi: 10.1111/bjd.12992. Epub 2014 Aug 5. Br J Dermatol. 2014. PMID: 24665924 No abstract available.
Treatment with 311-nm ultraviolet B enhanced response of psoriatic lesions in ustekinumab-treated patients: a randomized intraindividual trial.
Wolf P, Weger W, Legat FJ, Posch-Fabian T, Gruber-Wackernagel A, Inzinger M, Salmhofer W, Hofer A. Wolf P, et al. Br J Dermatol. 2012 Jan;166(1):147-53. doi: 10.1111/j.1365-2133.2011.10616.x. Br J Dermatol. 2012. PMID: 21910714 Clinical Trial.
Randomized double-blinded placebo-controlled intra-individual trial on topical treatment with a 1,25-dihydroxyvitamin D₃ analogue in polymorphic light eruption.
Gruber-Wackernagel A, Bambach I, Legat FJ, Hofer A, Byrne SN, Quehenberger F, Wolf P. Gruber-Wackernagel A, et al. Br J Dermatol. 2011 Jul;165(1):152-63. doi: 10.1111/j.1365-2133.2011.10333.x. Epub 2011 May 30. Br J Dermatol. 2011. PMID: 21428979 Clinical Trial.
Desired response to phototherapy vs photoaggravation in psoriasis: what makes the difference?
Wolf P, Weger W, Patra V, Gruber-Wackernagel A, Byrne SN. Wolf P, et al. Among authors: gruber wackernagel a. Exp Dermatol. 2016 Dec;25(12):937-944. doi: 10.1111/exd.13137. Exp Dermatol. 2016. PMID: 27376966
Polymorphous light eruption: clinic aspects and pathogenesis.
Gruber-Wackernagel A, Byrne SN, Wolf P. Gruber-Wackernagel A, et al. Dermatol Clin. 2014 Jul;32(3):315-34, viii. doi: 10.1016/j.det.2014.03.012. Dermatol Clin. 2014. PMID: 24891054 Review.
Photohardening of polymorphic light eruption patients decreases baseline epidermal Langerhans cell density while increasing mast cell numbers in the papillary dermis.
Wolf P, Gruber-Wackernagel A, Bambach I, Schmidbauer U, Mayer G, Absenger M, Fröhlich E, Byrne SN. Wolf P, et al. Exp Dermatol. 2014 Jun;23(6):428-30. doi: 10.1111/exd.12427. Exp Dermatol. 2014. PMID: 24758562
29 results
Jump to page
Feedback